etisulergine has been researched along with 2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin in 1 studies
*2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin: potent, specific D2 dopamine receptor agonist; RN given refers to parent cpd [MeSH]
*2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin: potent, specific D2 dopamine receptor agonist; RN given refers to parent cpd [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Closse, A; Frick, W; Jaton, A; Seiler, MP; Stoll, AP; Vigouret, JM | 1 |
1 other study(ies) available for etisulergine and 2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin
| Article | Year |
|---|---|
Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
Topics: Animals; Antiparkinson Agents; Binding Sites; Cattle; In Vitro Techniques; Naphthalenes; Rats; Receptors, Dopamine; Structure-Activity Relationship; Tetrahydronaphthalenes | 1986 |